Advertise here
Advertise here

Dupilumab Approved for Chronic Spontaneous Urticaria

, 2025-04-18 17:06:00 The US Food and Drug Administration (FDA) has approved dupilumab for the treatment of chronic spontaneous urticaria (CSU) in patients aged 12 years and older who “remain symptomatic despite H1 antihistamine treatment,” according to a press release from the manufacturers, Regeneron Pharmaceuticals and Sanofi.  Approval follows the FDA’s request in October 2023…

Read More

RFK Jr. Is Giving Families ‘False Hope’ By Claiming He’ll Figure Out Cause of Autism by September, Former FDA Vaccine Head Warns

, 2025-04-18 15:22:00 Dr. Peter Marks, the former top vaccine official at the U.S. Food and Drug Administration (FDA), has criticized Health and Human Services Secretary Robert F. Kennedy Jr. for giving what he called “false hope” to families by claiming that the Trump administration will identify the cause of autism by September. Marks, who…

Read More

Medical Device Right to Repair is the Wrong Approach

Peter J. Pitts , 2025-04-18 13:55:00 Americans are becoming more familiar with the right to repair movement that is shaking up industries from agriculture to consumer electronics. The notion is that consumers should be empowered to hire whoever they want to fix their own technologies, regardless of expertise or oversight. In fact, as of 2025…

Read More

Eli Lilly, Novo Nordisk, FDA, Makary, GSK

Meghana Keshavan , 2025-04-18 13:02:00 Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today we talk about Eli Lilly’s stock jumping after it released new data on its GLP-1 pill, see Sanofi partner with a mysterious company, and more. A very…

Read More

Bruker introduces nVista 2P miniature microscope

, 2025-04-18 10:48:00 Bruker Corporation today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving animals. It leverages advanced two-photon fluorescence microscopy technology to enable high-resolution imaging at greater depths with 3D data reconstruction, providing researchers with unprecedented insights into neuronal activity. Featuring several…

Read More

FDA Authorizes First Digital Therapeutic for Migraine

, 2025-04-18 13:29:00 The US Food and Drug Administration (FDA) has granted marketing authorization to CT-132 (Click Therapeutics), an adjunctive, first-in-class prescription digital therapeutic for the preventive treatment of episodic migraine in adults, its development company announced in a statement. The mobile smartphone app uses biological, psychologic, and behavioral approaches to target pain processing and…

Read More

We’re reading about FDA layoffs, pharma tariffs

Ed Silverman , 2025-04-18 13:54:00 And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We expect to promenade with the official mascots and catch up on our reading, and…

Read More

Why insurance companies are denying coverage for prosthetic limbs

, 2025-04-18 12:13:00 Why insurance companies are denying coverage for prosthetic limbsPlay PBS News Weekend’s Ali Rogin spoke with KFF Health News contributor Michelle Andrews about what some people with missing limbs consider a disparity in health insurance coverage: Though a knee replacement likely would be covered, a prosthetic knee isn’t always. A prosthetic device…

Read More

Wildfire Smoke Linked to Increase in Mental Health ED Visits

, 2025-04-18 13:21:00 TOPLINE: Exposure to fine particulate matter (PM2.5) from the 2020 California wildfires was linked to an increase in mental health-related emergency department (ED) visits within 7 days of exposure, including increases of 8% for all-cause mental health, 15% for depression, and 29% for other mood-affective disorders, a new study showed. METHODOLOGY: Data…

Read More

When Patients Win,  Everyone Wins

Suzanne Harris , 2025-04-18 13:00:00 If someone asked if your company or product was patient-centric, you would likely respond with an enthusiastic yes. Let’s probe a bit deeper… When was the last time you asked a patient to contribute to trial design? Have you ever asked a patient to contribute to a protocol? If you’re…

Read More

Study highlights underrepresentation of ethnic minorities in research on multiple long-term conditions

, 2025-04-18 11:18:00 New research shows that ethnic minorities are underrepresented in studies into multiple long-term conditions (MLTCs), despite being more likely to be affected. A systematic review published in the Journal of the Royal Society of Medicine found a lack of reporting on ethnicity and underrepresentation of ethnic minority groups in intervention studies to…

Read More

Abortion Rates Stable in Canada but Spike Elsewhere

, 2025-04-18 11:12:00 Abortion rates increased substantially from 2020 to 2023 in the United Kingdom and Europe, but not in Canada, a new study found. “We are not seeing this kind of dramatic spike in abortion rates in Ontario, which has about 40% of the Canadian population,” lead author Laura Schummers, assistant professor of pharmaceutical…

Read More

How Trump AI strategy differs sharply from Biden’s

Casey Ross and Brittany Trang , 2025-04-18 08:30:00 Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. Brittany Trang, Ph.D., is a health tech reporter at STAT and writes the AI Prognosis newsletter. Follow her on Threads, Mastodon, and Bluesky. You can reach Brittany on…

Read More

Some lung cancer patients maintain long-term control after stopping immunotherapy

, 2025-04-18 05:16:00 Bottom line: A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due to immune-related adverse events (irAEs) continued to experience long-term disease control. Journal in which the study was published: Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR) Authors:…

Read More

BMA Loses Legal Challenge Against GMC Over Associates

, 2025-04-18 09:11:00 The British Medical Association (BMA) has lost a High Court challenge against the General Medical Council over its regulation of associate professions.  The BMA took legal action last year, arguing that the GMC’s use of the term “medical professionals” to describe both doctors and associates blurred important distinctions and risked patient safety….

Read More

And now for the science bit…

Terence Cosgrave , 2025-04-18 07:33:00 To compete with the other countries out there means a substantial investment from the Irish government in research and development, writes Terence Cosgrave I don’t think the Pope has ever described the exact length that a woman’s dress should be. The Church was very worried for a time about women’s…

Read More

What RadNet’s latest acquisition says about AI in radiology

Katie Palmer , 2025-04-17 08:30:00 Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can reach Katie on Signal at palmer.01. RadNet, which runs nearly 400 radiology imaging centers in the United States, wants to…

Read More

Michigan and Pennsylvania join six other states with measles outbreaks. Here’s what to know

, 2025-04-18 08:07:00 Health and Human Services Secretary Robert F. Kennedy Jr., left, arrives at Reinlander Mennonite Church after a second measles death, Sunday, April 6, 2025, in Seminole, Texas. Credit: AP Photo/Annie Rice Michigan officials confirmed a new measles outbreak Thursday near Grand Rapids, bringing the U.S. to eight states with active outbreaks of…

Read More

Africa CDC and WHO strengthen mpox response with updated strategy

, 2025-04-18 05:20:00 Africa CDC and WHO have updated their joint Continental Response Plan for the mpox emergency as the disease continues to affect new areas. The revised strategy focuses on controlling outbreaks, while expanding vaccination coverage and transitioning toward a longer-term, sustainable response.  Mpox is a viral illness that spreads between people, mainly through…

Read More

Cannabis Use in Gastroparesis May Increase Healthcare Burden

, 2025-04-18 06:07:00 TOPLINE: Cannabis use in patients with gastroparesis increased and was associated with increased odds of emergency department (ED) visits and hospitalizations but reduced esophagogastroduodenoscopy rates. METHODOLOGY: To manage gastroparesis symptoms, little evidence exists for the theoretical benefits of cannabinoids, and their safety has not been well established, despite increased use among patients….

Read More

Digital dementia support project gets $2M federal funding and more briefs

, 2025-04-18 06:06:00 $2M funding for carers of CALD people with dementia Independent non-profit National Ageing Research Institute (NARI) has received federal grant funding for its project enabling digital support for culturally and linguistically diverse (CALD) people with dementia. It obtained A$2.9 million ($1.8 million) from the Medical Research Future Fund for its five-year project, which…

Read More

FDA Okays Osilodrostat for Treating Cushing Syndrome

, 2025-04-18 03:35:00 The US Food and Drug Administration (FDA) has approved a new indication for osilodrostat (Isturisa, Recordati) as second-line treatment of endogenous hypercortisolemia in adults with Cushing syndrome. Endogenous Cushing syndrome is a condition of excess cortisol that can result in complications such as weight gain, hyperglycemia, hypertension, osteoporosis, thin skin, and muscle…

Read More

Brexpiprazole Effective for Schizophrenia in Teens

, 2025-04-18 04:15:00 TOPLINE: Brexpiprazole was associated with a greater reduction in schizophrenia symptoms over 6 weeks in adolescents compared with placebo, with a tolerable safety profile, in a new phase 3 trial. METHODOLOGY: Researchers conducted a randomized, double-blind, parallel-arm, placebo-controlled, phase 3 trial with an active reference across 10 countries between 2017 and 2023….

Read More

FDA clears Leos laser system for glaucoma

, 2025-04-17 18:35:00 April 17, 2025 1 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request….

Read More
Advertise here
error: Content is protected !!